Early Detection of Treatment Response to Mavacamten in Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Regurgitation Using Magnetocardiography
ABSTRACT Recent evidence highlights the efficacy of mavacamten in reducing left ventricular outflow tract (LVOT) gradients in patients with hypertrophic cardiomyopathy (HCM), which is illustrated in this case. Additionally, the potential of magnetocardiography (MCG) as a novel, objective diagnostic...
Saved in:
| Main Authors: | Phillip Suwalski, Gamze Satilmis, Markus Reinthaler, Ulf Landmesser, Bettina Heidecker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.70667 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An ALPK3 truncation variant causing autosomal dominant hypertrophic cardiomyopathy is partially rescued by mavacamten
by: Lisa Leinhos, et al.
Published: (2025-03-01) -
Effect of Mavacamten on Echocardiographic Features in Chinese Patients with Obstructive Hypertrophic Cardiomyopathy: Results from the EXPLORER-CN Study
by: Zhuang Tian, et al.
Published: (2025-04-01) -
MitraClip combined with PTSBME for the treatment of obstructive hypertrophic cardiomyopathy with severe mitral regurgitation: a case report
by: Xuewen Wang, et al.
Published: (2025-03-01) -
Tale of three services: early UK experience with mavacamten treatment for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction
by: Jane Draper, et al.
Published: (2025-04-01) -
Exercise‐induced dynamic mitral regurgitation is associated with outcomes in patients with ischaemic cardiomyopathy
by: Maximilian Spieker, et al.
Published: (2025-06-01)